Comprehend Prepares To Launch New Clinical Trials Tracking System
This article was originally published in The Gray Sheet
At the upcoming DIA meeting in Washington, Silicon Valley-based Comprehend will unveil a new continuous quality computer application specifically designed to help medical device and other life science companies efficiently access, understand, and analyze their clinical data.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.